ALX Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALX Oncology and other ETFs, options, and stocks.About ALXO
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.
CEOJason Lettmann
CEOJason Lettmann
Employees80
Employees80
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees80
Employees80
ALXO Key Statistics
Market cap77.42M
Market cap77.42M
Price-Earnings ratio-0.73
Price-Earnings ratio-0.73
Dividend yield—
Dividend yield—
Average volume269.15K
Average volume269.15K
High today$1.50
High today$1.50
Low today$1.35
Low today$1.35
Open price$1.50
Open price$1.50
Volume104.58K
Volume104.58K
52 Week high$2.27
52 Week high$2.27
52 Week low$0.404
52 Week low$0.404
Stock Snapshot
The current ALX Oncology(ALXO) stock price is $1.38, with a market capitalization of 77.42M. The stock trades at a price-to-earnings (P/E) ratio of -0.73.
During the trading session on 2026-01-14, ALX Oncology(ALXO) shares reached a daily high of $1.50 and a low of $1.35. At a current price of $1.38, the stock is +2.2% higher than the low and still -8.0% under the high.
Trading activity shows a volume of 104.58K, compared to an average daily volume of 269.15K.
Over the past 52 weeks, ALX Oncology(ALXO) stock has traded between a high of $2.27 and a low of $0.40.
Over the past 52 weeks, ALX Oncology(ALXO) stock has traded between a high of $2.27 and a low of $0.40.
People also own
Based on the portfolios of people who own ALXO. This list is generated using Robinhood data, and it’s not a recommendation.